Renal Function Disorder Clinical Trial
Official title:
Virtual Reality for for Pain and Anxiety Distraction Strategy on Peritoneal Catheter Insertion: A Pilot Study
This clinical trial aims to investigate the effect of VR application on reducing preoperative anxiety and the intraoperative and postoperative pain of patients who undergo peritoneal dialysis catheter insertion. The main questions it aims to answer are: 1) Whether preoperative VR application can reduce preoperative anxiety in patients undergoing peritoneal dialysis catheter insertion; 2) Whether intraoperative VR application can reduce intraoperative and postoperative pain in patients undergoing peritoneal dialysis catheter insertion; 3) Whether VR application can improve patients satisfaction of the operation. Participants will be randomly assigned to the VR group and control group, and participants in the VR group will be introduced to VR use and watch a VR video about the operating room environment 1 day before the surgery. During the procedure, participants in the VR group will watch a soothing video through the VR device. In contrast, participants in the control group will receive the usual preoperative and surgical procedures. Preoperative anxiety, intraoperative and postoperative pain, and patient satisfaction will be compared between the two arms.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | October 30, 2023 |
Est. primary completion date | October 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age 18-65 years, male or female. - Patients receiving PD catheter insertion for the first time. - Signed informed consent form. Exclusion Criteria: - Hearing and vision impairments, or affective disorder. - Communication is not possible due to impaired cognitive ability. - History of epilepsy or seizure. - History of long-term use of pain medication (opioids). - History of severe cardiac failure (NYHA IV), acute myocardial infarction, or severe acute infection in recent three months. - Patients who refuse to use VR. - Other conditions deemed unsuitable by physicians. |
Country | Name | City | State |
---|---|---|---|
China | First affiliated hospital of Sun Yat-sen University | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
First Affiliated Hospital, Sun Yat-Sen University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | VR Questionnaire | Tolerability, feasibility and satisfaction of VR use | within 30 minutes after surgery | |
Other | Catheter insertion related complications | including peri-operative complications (bleeding, bowel injury), mechanical complication (drainage failure, displacement, fluid leak), infective complications (exit site, tunnel, peritonitis), and other catheter insertion related complications. | through study completion, an average of 10 days | |
Primary | Procedure-related pain | Measured by Visual Analogue Scale (VAS) pain measurement scale divided from 0 to 10 where 0 is no pain and 10 worst pain that can be imagined. | recorded within 30 minutes after surgery | |
Primary | Anxiety assessment 30 minutes before surgery | State-Trait Anxiety Scale (STAI) was applied in the preoperative period, and only the 20-item state scale construct was used. | 30 minutes before surgery | |
Primary | Patient satisfaction | 5-point Likert verbal rating scale: 5, extremely satisfied; 4, satisfied; 3, undecided; 2, dissatisfied; 1, extremely dissatisfied. | within 30 minutes after surgery | |
Secondary | Postoperative analgesics usage | The use of paracetamol, NSAIDs, opioids, and other analgesics administered to the patients after surgery to relieve the pain caused by the operation. | after the operation until discharge from hospital | |
Secondary | Distribution of systolic blood pressure of patients in the intraoperative period | Difference between the highest value during the operation and the baseline value. | Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded. | |
Secondary | Distribution of diastolic blood pressure of patients in the intraoperative period | Difference between the highest value during the operation and the baseline value. | Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded. | |
Secondary | Distribution of pulse rates of patients in the intraoperative period | Difference between the highest value during the operation and the baseline value. | Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded. | |
Secondary | Distribution of respiratory rates of patients in the intraoperative period | Difference between the highest value during the operation and the baseline value. | Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded. | |
Secondary | Patient reported pain post procedure | Measured by Visual Analogue Scale (VAS) pain measurement scale divided from 0 to 10 where 0 is no pain and 10 worst pain that can be imagined. | recorded at 4 hours post operation, and 24 hour intervals to four days post operation. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02522104 -
Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)
|
Phase 4 | |
Completed |
NCT00721773 -
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
|
N/A | |
Enrolling by invitation |
NCT02256579 -
Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients
|
N/A | |
Completed |
NCT04069871 -
Transcutaneous Electrical Nerve Stimulation for Tissues Perfusion
|
N/A | |
Active, not recruiting |
NCT05087537 -
Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve
|
N/A | |
Active, not recruiting |
NCT05054972 -
Left Renal Vein Division for Juxtarenal Aortic Exposure
|
||
Not yet recruiting |
NCT05112393 -
Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation
|
||
Recruiting |
NCT05462938 -
Conscious Sedation for Transcatheter Aortic Valve Implantation
|
N/A | |
Recruiting |
NCT04272359 -
Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
|
||
Completed |
NCT01255020 -
Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients
|
N/A | |
Active, not recruiting |
NCT03002415 -
The Effect of Water Intake on the State of Hydration and Renal Function in Elderly Patients
|
N/A | |
Active, not recruiting |
NCT04242758 -
Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy
|
Phase 4 | |
Withdrawn |
NCT00936923 -
Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients
|
Phase 3 | |
Recruiting |
NCT04028323 -
Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
|
Phase 4 | |
Completed |
NCT04070885 -
Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.
|
||
Completed |
NCT02549066 -
Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation
|
N/A | |
Not yet recruiting |
NCT02061566 -
Indoxyl Sulfate Induces Leukocyte-endothelial Interactions Through Up-regulation of ICAM-1 in Acute Kidney Injury
|
N/A | |
Not yet recruiting |
NCT05134077 -
Influence of Simple Renal Cysts on Renal Function
|
N/A | |
Completed |
NCT02013596 -
Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum
|
N/A | |
Completed |
NCT02443363 -
Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault?
|
N/A |